Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.
N Engl J Med. 2012 Oct 25;367(17):1616-25. doi: 10.1056/NEJMoa1204410.
Chemotherapy for metastatic lung or colorectal cancer can prolong life by weeks or months and may provide palliation, but it is not curative.
We studied 1193 patients participating in the Cancer Care Outcomes Research and Surveillance (CanCORS) study (a national, prospective, observational cohort study) who were alive 4 months after diagnosis and received chemotherapy for newly diagnosed metastatic (stage IV) lung or colorectal cancer. We sought to characterize the prevalence of the expectation that chemotherapy might be curative and to identify the clinical, sociodemographic, and health-system factors associated with this expectation. Data were obtained from a patient survey by professional interviewers in addition to a comprehensive review of medical records.
Overall, 69% of patients with lung cancer and 81% of those with colorectal cancer did not report understanding that chemotherapy was not at all likely to cure their cancer. In multivariable logistic regression, the risk of reporting inaccurate beliefs about chemotherapy was higher among patients with colorectal cancer, as compared with those with lung cancer (odds ratio, 1.75; 95% confidence interval [CI], 1.29 to 2.37); among nonwhite and Hispanic patients, as compared with non-Hispanic white patients (odds ratio for Hispanic patients, 2.82; 95% CI, 1.51 to 5.27; odds ratio for black patients, 2.93; 95% CI, 1.80 to 4.78); and among patients who rated their communication with their physician very favorably, as compared with less favorably (odds ratio for highest third vs. lowest third, 1.90; 95% CI, 1.33 to 2.72). Educational level, functional status, and the patient's role in decision making were not associated with such inaccurate beliefs about chemotherapy.
Many patients receiving chemotherapy for incurable cancers may not understand that chemotherapy is unlikely to be curative, which could compromise their ability to make informed treatment decisions that are consonant with their preferences. Physicians may be able to improve patients' understanding, but this may come at the cost of patients' satisfaction with them. (Funded by the National Cancer Institute and others.).
转移性肺癌或结直肠癌的化疗可以延长数周或数月的生命,并可能提供缓解,但无法治愈。
我们研究了 1193 名参加癌症护理结果研究和监测(CanCORS)研究(一项全国性、前瞻性、观察性队列研究)的患者,他们在诊断后 4 个月存活,并接受新诊断的转移性(IV 期)肺癌或结直肠癌的化疗。我们试图描述对化疗可能具有治愈性的期望的普遍性,并确定与这种期望相关的临床、社会人口统计学和卫生系统因素。数据来自于专业访谈员对患者进行的问卷调查,以及对医疗记录的全面审查。
总体而言,69%的肺癌患者和 81%的结直肠癌患者表示不了解化疗根本不可能治愈他们的癌症。在多变量逻辑回归中,与肺癌患者相比,结直肠癌患者报告对化疗的不准确信念的风险更高(优势比,1.75;95%置信区间[CI],1.29 至 2.37);与非西班牙裔白人患者相比,非裔和西班牙裔患者(西班牙裔患者的优势比,2.82;95%CI,1.51 至 5.27;黑人患者的优势比,2.93;95%CI,1.80 至 4.78);与对与医生的沟通评价非常好的患者相比,评价较差的患者(与最低三分之一相比,最高三分之一的优势比,1.90;95%CI,1.33 至 2.72)。教育程度、功能状态和患者在决策中的角色与对化疗的这种不准确信念无关。
许多接受化疗治疗不可治愈癌症的患者可能不了解化疗不太可能治愈,这可能会影响他们做出符合自身偏好的知情治疗决策的能力。医生可能能够提高患者的认识,但这可能会以牺牲患者对他们的满意度为代价。(由美国国立癌症研究所等资助)。